NVCN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 Apr 2023 @ 16:00):

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally...

Stats
Today's Volume	1.00
Average Volume	25 784.00
Market Cap	82.86M
EPS	$0 ( 2024-03-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.993
ATR14	$0.436 (1.45%)

Volume Correlation

Long: 0.10 (neutral)

Short: 0.00 (neutral)

Signal:(63.994) Neutral

Neovasc Inc Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Neovasc Inc Correlation - Currency/Commodity

0.82
( strong )

0.91
( very strong )

0.88
( strong )

-0.40
( neutral )

0.76
( moderate )

-0.76
( moderate negative )

Neovasc Inc Financials

Annual	2022
Revenue:	$3.81M
Gross Profit:	$3.03M (79.66 %)
EPS:	$-15.07

Q4	2022
Revenue:	$1.45M
Gross Profit:	$1.19M (82.13 %)
EPS:	$-5.06

Q3	2022
Revenue:	$923 311
Gross Profit:	$703 281 (76.17 %)
EPS:	$-3.10

Q2	2022
Revenue:	$818 060
Gross Profit:	$660 133 (80.69 %)
EPS:	$-3.08

Financial Reports:

No articles found.

Neovasc Inc

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.